What do you want to do today?
video_library
Watch On Demand
auto_awesome_motion
Discover Series
person_search
Search KOLs
campaign
Meet our Ambassadors
group_work
Meet Societies
handshake
Meet Partners
video_library
OnDemand
auto_awesome_motion
Series
person_search
Faculty
campaign
Ambassa-
dors
group_work
Societies
handshake
Partners

Only logged in users can watch the content

Chat keyboard_arrow_down
Description keyboard_arrow_down
Existing therapeutic strategies to treat LUTS due to BPH range from observation and medical treatment to a variety of surgical treatment modalities. TURP has been the treatment method of choice (even if is accompanied by a substantial perioperative morbidity rate and postoperative complications). More recently, transurethral enucleation techniques using different energy sources of laser have become the standard for larger gland sizes. There is significant interest in the development of minimally invasive surgical techniques (MISTs) for LUTS due to BPH that can be performed in an office or ambulatory setting under local anesthesia, ensure rapid and durable symptom relief, and provide a favorable safety profile (avoiding the risk of significant postoperative complications, including the development of anejaculation and/ or sexual dysfunction), as an alternative to traditional TURP or laser enucleation. In this interesting episode of AIS, we will discuss one of the most innovative and efficient MISTs available to treat LUTS due to BPH, the temporary implanted nitinol device, the so-called iTind. We will see how it works, how to properly select a patient, how and where to perform the procedure, and we will review the clinical data available.

  1. Welcome & Introduction - Dr. Pascal Mancuso (Australia)

  1. Minimally invasive options for BPH - Dr. Pascal Mancuso (Australia)

  1. iTind procedure using a flexible cystoscope: technique, advantages, limitations, my personal experience - Dr. David Brown (Australia)

  1. iTind procedure using a rigid cystoscope: technique, advantages, limitations, my personal experience - Dr. Suntchai Wirotsaengthong (Thailand)

  1. The best site of care for iTind: office vs OR - Dr. Suntchai Wirotsaengthong (Thailand) /Dr. Silvia Secco (Italy)

  1. BPH symptoms relief from a patient's point of view 

  1. Clinical evidence on iTind - Dr. David Brown (Australia)

  1. Training pathway - lessons learned and recommendations - Dr. David Brown (Australia)

  2. Discussion and closing remarks - All faculty moderated by Dr. Silvia Secco (Italy)
Faculty keyboard_arrow_down
Dr. David Brown FRCS Ed, FRACS, Consultant Urological Surgeon, Redcliffe Hospital, Australia Urology
Dr. Pascal Mancuso Head, Urology Department, Liverpool Hospital, Australia Urology
Dr. Silvia Secco MD, Urology Consultant - ASST Grande Ospedale Metropolitano Niguarda, Italy Urology
Dr. Suntchai Wirotsaengthong MD, Urologist, Department of Surgery, BNH Hospital; Consultant Urologist, Taksin Hospital, Bangkok Metropolitan Administration, Thailand Urology
In collaboration with keyboard_arrow_down
Olympus
Related Content keyboard_arrow_down